AMANDA CAIRNES: Open Payments
NPI 1720759145 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 37 payments from 12 companies in 2025. Trend: 2023 $210 · 2024 $788 · 2025 $835
Food & beverage: $756Education: $79
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $262 |
| ABBVIE INC. | 13 | $210 |
| Aimmune Therapeutics, Inc. | 3 | $74 |
| Ardelyx, Inc. | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| PFIZER INC. | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $21 |
Products named: TREMFYA, RINVOQ, ZENPEP, MAVYRET, IBSRELA, ENTYVIO, DUPIXENT, XIFAXAN.
Industry payments across NC — which companies pay providers there.
